行情

PRAH

PRAH

PRA Health
NASDAQ

实时行情|Nasdaq Last Sale

105.52
-1.38
-1.29%
盘后: 105.85 +0.33 +0.32% 16:12 11/21 EST
开盘
107.28
昨收
106.90
最高
107.35
最低
105.22
成交量
38.20万
成交额
--
52周最高
121.98
52周最低
82.12
市值
66.73亿
市盈率(TTM)
29.37
分时
5日
1月
3月
1年
5年

分析师评级

13位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

PRAH 新闻

  • Edited Transcript of PRAH earnings conference call or presentation 31-Oct-19 1:00pm GMT
  • Thomson Reuters StreetEvents.9小时前
  • Triangle company to spearhead new age of drug development
  • American City Business Journals.12小时前
  • Here's Why You Should Retain PRA Health (PRAH) Stock Now
  • Zacks.1天前
  • J&J launches innovative study for expanded use of Invokana
  • Seeking Alpha - Article.3天前

更多

所属板块

生物技术和医学研究
-0.31%
制药与医学研究
+0.32%

热门股票

名称
价格
涨跌幅

PRAH 简况

PRA Health Sciences, Inc. is a contract research organization. The Company provides outsourced clinical development services to the biotechnology and pharmaceutical industries. The Company offers therapeutic services in areas of pharmaceutical development, including oncology, central nervous system, inflammation and infectious diseases. Its services include data management, statistical analysis, clinical trial management, and regulatory and drug development consulting. It provides its clients with clinical development service offerings, which includes both traditional, project-based Phase I through Phase IV services, as well as embedded and functional outsourcing services. As of December 31, 2016, its clinical development platform included approximately 70 offices across North America, Europe, Asia, Latin America, South Africa, Australia and the Middle East. The Company's service offerings include product registration, strategic solutions and early development services.
展开

Webull提供PRA Health Sciences Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。